Development of chiral terminal-alkene-phosphine hybrid ligands for palladium-catalyzed asymmetric allylic substitutions.Org Lett. 2010 Jul 02; 12(13):3054-7.OL
Abstract
A variety of novel chiral terminal-alkene-phosphine hybrid ligands were successfully developed from diethyl L-tartrate for palladium-catalyzed asymmetric allylic alkylations, etherifications, and amination to give the desired products in excellent yields and ee's.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
20536224
Citation
Liu, Zhaoqun, and Haifeng Du. "Development of Chiral Terminal-alkene-phosphine Hybrid Ligands for Palladium-catalyzed Asymmetric Allylic Substitutions." Organic Letters, vol. 12, no. 13, 2010, pp. 3054-7.
Liu Z, Du H. Development of chiral terminal-alkene-phosphine hybrid ligands for palladium-catalyzed asymmetric allylic substitutions. Org Lett. 2010;12(13):3054-7.
Liu, Z., & Du, H. (2010). Development of chiral terminal-alkene-phosphine hybrid ligands for palladium-catalyzed asymmetric allylic substitutions. Organic Letters, 12(13), 3054-7. https://doi.org/10.1021/ol101069y
Liu Z, Du H. Development of Chiral Terminal-alkene-phosphine Hybrid Ligands for Palladium-catalyzed Asymmetric Allylic Substitutions. Org Lett. 2010 Jul 2;12(13):3054-7. PubMed PMID: 20536224.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Development of chiral terminal-alkene-phosphine hybrid ligands for palladium-catalyzed asymmetric allylic substitutions.
AU - Liu,Zhaoqun,
AU - Du,Haifeng,
PY - 2010/6/12/entrez
PY - 2010/6/12/pubmed
PY - 2010/9/21/medline
SP - 3054
EP - 7
JF - Organic letters
JO - Org Lett
VL - 12
IS - 13
N2 - A variety of novel chiral terminal-alkene-phosphine hybrid ligands were successfully developed from diethyl L-tartrate for palladium-catalyzed asymmetric allylic alkylations, etherifications, and amination to give the desired products in excellent yields and ee's.
SN - 1523-7052
UR - https://www.unboundmedicine.com/medline/citation/20536224/Development_of_chiral_terminal_alkene_phosphine_hybrid_ligands_for_palladium_catalyzed_asymmetric_allylic_substitutions_
DB - PRIME
DP - Unbound Medicine
ER -